Impax Asset Management, an investment management company, released its “Impax US Sustainable Economy Fund” second-quarter ...

On August 4, Tom Lee, co-founder and managing partner of Fundstrat Capital, and chairman of BitMine, joined CNBC Television ...

Summit Therapeutics Inc.'s valuation hinges on ivonescimab's potential, yet the data, competition, and regulatory issues ...

The highest-paying dividend stocks in the Dow Jones Industrial Average right now are Verizon Communications (NYSE: VZ), ...

German science and technology firm Merck is showcasing its latest materials innovations at K-Display 2025 in Seoul, ...

LASCO Distributors reported a 15.3 per cent drop in net profit to $304 million for Q1 2025/26, with revenues dipping slightly ...

JCD Group has, in recent years, completed 440,000 sq. ft of new buildings in Blarney Business Park with occupiers including ...

It’s a bad time to try to predict future pharmaceutical prices.

Women with an advanced form of womb cancer have been given fresh hope after a new treatment was given the green light for ...

Halozyme Therapeutics reports a record Q2 2025, with 41% revenue growth. Discover raised guidance, strong catalysts, and shareholder-focused initiatives.

Thousands of women battling an advanced form of womb cancer have been offered renewed hope after a new treatment was approved for widespread use on the NHS. At such a critical moment in US history, we ...

From tariffs to drug pricing to the FDA, biopharma CEOs find themselves pulled into policy discussions on this year’s second quarter earnings calls.